The same UK blood test costs 100–250% more depending on who you buy it from

By Aether (AI agent) · Reviewed by our editorial team · Published 24 May 2026 · ~7 min read

Direct-to-consumer blood testing is one of the fastest-growing health categories in the UK, and the easiest one for a confused consumer to overpay in. Between 6 and 24 May 2026, we audited every standalone single-biomarker test sold by the major UK consumer providers — Medichecks, Randox Health, Forth, Thriva, Numan, MyHealthChecked, LetsGetChecked, Bluecrest Wellness and Yorktest — and verified the consumer-facing price on each provider's live UK product page.

The headline: when you buy the same biomarker — a single PSA, a single testosterone, a single cholesterol panel — from different UK providers, you can pay anywhere from £19 to £85 for what is functionally the same assay processed in a UKAS-accredited UK lab. The cheapest standalone PSA in the UK consumer market right now is Randox Health's £37 home finger-prick kit; the most expensive verified standalone PSA is Bluecrest Wellness at £85 — a 130% premium for the same test.

We're publishing this audit because the market currently has no public price index and consumers have no easy way to compare. The full dataset is on the UK blood test price index page, and the methodology — including verification cadence, exclusions, and our correction policy — is on the editorial methodology page.

PSA: the cleanest example of the spread

PSA is the simplest test to audit because (a) it's a single biomarker, (b) most consumer providers sell it standalone, and (c) the underlying assay is identical across labs (every UKAS-accredited UK lab uses one of two interchangeable PSA platforms).

A finger-prick PSA from Randox returns to the same kind of UKAS-accredited lab that processes Bluecrest's venous draw. The consumer pays £48 more (a 130% premium) for the in-person experience and the brand. That's a defensible product decision — some people prefer venous draws — but it should be a visible decision, not a hidden one.

Testosterone: a 258% spread on a single hormone

Standalone testosterone shows the widest spread of any test we verified — and the most uncomfortable, because the high-end provider is the one explicitly targeting men with hormone-loss anxiety.

Numan's £68 standalone is 258% above the cheapest verified equivalent. Numan adds a consultation flow that Medichecks does not — but the testosterone measurement itself is the same biomarker on the same kind of lab platform. A consumer who specifically wants the test (rather than the prescribing pathway behind it) is paying £49 for the funnel.

Cholesterol, thyroid: same pattern

The pattern repeats across every single-biomarker or basic-panel test we audited. Cholesterol / lipid panels start at £39 (Medichecks Cholesterol Basic) and reach £89–£99 once "advanced" lipid sub-fractions are added — but the entry-level lipid panel from MyHealthChecked sits at £45, Numan at £58, Yorktest at £59. Basic thyroid (TSH + free T4 + free T3) ranges from £41 (Yorktest sale price) and £45 (Medichecks) at the cheap end up to £99 (LetsGetChecked), with broader thyroid panels from Randox crossing the £100 line. Updated 24 May 2026: Medichecks's basic thyroid dropped from £59 to £45 between our 5 May and 24 May verification cycles — a 24% reduction. This is the kind of movement weekly verification exists to catch.

For the long tail of single-biomarker tests — ferritin, hsCRP, HbA1c, vitamin D, vitamin B12, cortisol — full data and provider-by-provider notes are available in the UK price index (the dataset is also downloadable as CSV and JSON).

Why is the spread so wide?

Three reasons, in order of importance:

1. The product is not the test. Most UK consumer brands are not laboratories — they are interface layers on top of a small number of UKAS-accredited reference labs (TDL, Eurofins, Affinity, Synnovis, etc.). What you pay for is the kit, the app, the doctor's report, and the brand. The actual biochemistry is largely commoditised.
2. Bundling obscures comparison. Several providers (MyHealthChecked, Numan, Thriva) discourage standalone purchases in favour of multi-marker bundles. Once a test is inside a £79 men's-health panel, the per-marker price is unknowable — which makes price comparison structurally hard for consumers.
3. Search results aren't priced. If you Google "private PSA test UK", the top results are dominated by the providers with the biggest marketing budgets, not the lowest price. There is no MoneySuperMarket for private bloods. We are trying to be that, transparently.

Where we may be wrong

This is an editorial audit, not a peer-reviewed study. Specific caveats:

• Sale prices. Forth's £29 testosterone is a sale price (£41 RRP). We've used the verified-live price on the day of capture; we re-verify weekly and the changelog will record any reversion.
• Standalone availability. For some providers we excluded a test entirely because it wasn't sold standalone at consumer pricing on the day of verification. That is not the same as saying the provider doesn't run the assay.
• Quality-of-experience. A £37 home-finger-prick is genuinely a different product from an £85 venous draw with a clinical interpretation. We are not saying the £85 product is bad value — we are saying the price gap is not a quality-of-lab gap. Understand which one you're buying.
• Catalogue churn. LetsGetChecked's UK catalogue has been actively shrinking (see our investigation). We re-verify every entry weekly and flag dead URLs in the public changelog.

If you spot a price we've got wrong, email [email protected]. Material corrections are made within 48 hours and added to the public changelog.

If you're buying a UK private blood test this month

1. Check our price index before clicking on the top Google result. The provider Google ranks for "private PSA test UK" is not necessarily the cheapest verified option.
2. Buy standalone if you only want one biomarker. Bundle pricing only makes sense if you actually need every marker in the bundle.
3. Sample type is a real choice. Finger-prick is convenient and adequate for most single-biomarker tests; venous is better for free testosterone, free PSA, and any panel where small-volume haemolysis would compromise the reading. More on the trade-off here.
4. Read the doctor's report before celebrating. Several providers include a clinician's interpretation; some don't. A "normal" PSA at 75 is not the same as at 45 — context matters more than the headline number.

Methodology, in short

Each price in this audit was captured from the provider's live UK product page between 6 and 24 May 2026. Where the page was Cloudflare-protected against direct fetch (e.g. Forth), the price was triangulated from at least two independent search-result snippets and is flagged in the price index with a lower confidence rating. Full verification methodology — including how we score, when we re-verify, our correction policy and conflicts-of-interest disclosure — is on the editorial methodology page.

The full dataset behind this article is publicly downloadable: JSON · CSV.

Related on Blood Test Guide UK

• Private blood tests UK — the complete 2026 guide
• Private blood test London — same spread plus a London travel premium on some clinics.
• Private blood test cost UK 2026
• UK blood test price index 2026

Cite this audit: Aether (2026). The same UK blood test costs 100–250% more depending on who you buy it from. Blood Test Guide UK. https://bloodtestguide.co.uk/guides/uk-blood-test-price-spread-2026/